* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Document
Survey
Document related concepts
Oncogenomics wikipedia , lookup
Gene expression programming wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Designer baby wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Gene therapy wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Gene expression profiling wikipedia , lookup
Transcript
Ph.D. Student Enrolment Project Title : Cand.med Ida Bruun Kristensen : 1 September 2009 : "Osteoblast and osteoclast regulation in the pathophysiology of the bone disease in multiple myeloma" Supervisors : Professor, dr.med. Niels Abildgaard Senior Registrar, ph.d. Jacob Haaber Christensen, both Department of Haematology, Odense University Hospital,Professor, dr.med Henrik Ditzel, cand.scient, ph.d Maria Lyng Petersen, both Institute of Molecular Medicine, Cancer and Inflammation group Institute : Institute of Clinical Research Research Unit : Haematology Abstract: Aims: To reveal genes and cellular regulatory mechanisms of importance for development of osteolytic bone disease (OBD) in multiple myeloma. Background: Approximately 300 patients are each year in Denmark diagnosed with multiple myeloma. Two thirds of these patients have OBD at the time of diagnosis while most of the rest develops it during the course of the disease. OBD causes bone pain, hypercalciaemia and pathological fractures. OBD is known to be caused by an overactivation of the osteoclasts without compensatory osteoblast activation. The mechanisms of osteoblast inhibition are not clear. Material and Methods: Snap-frozen bone biopsies, bone-marrow aspirates, serum and urine samples are collected from all patients at the time-point of diagnostic work-up for multiple myeloma (inclusion ongoing) together with clinical data. Also bone-marrow biopsies and aspirates are collected from 20 healthy volunteers (inclusion ongoing). The material is added to a biobank with amplificated cDNA from malignant plasma cells from >170 multiple myeloma patients. Focused quantitative PCR (qPCR) analyses for ostelytic regulatory candidate genes (FRZB, HGF, SDC1, cMET) have been performed. Bone marrow aspirates are used for flow sorting of malignant plasma cells and mesenchymal steml cells (MSC). Gene expression profiling of MSC from patients with different degrees of OBD, MGUS and healthy volunteers is planned. Osteoblast isolation with Laser Capture Microdissection from slices of snap frozen bone marrow biopsies and gene expression profiling with qPCR are planned. Status: Patient inclusion ongoing (>30 included at present). Healthy volunteers have been recruited, material collection ongoing. qPCR of plasma cells from myeloma patients showed an association between expression of FRZB and degree of OBD (p<0.05), and an association between HGF and cMET expression and OS (p<0.05). A sorting protocol for malignant plasma cells (CD45/CD38+/CD138+) and the rare MSC (CD34-/CD45-/CD73+/CD271+) is currently evaluated, and amplification protocols of small amount of cDNA for gene expression profiling are being tested. Keywords: Oncology and Haematology